Companies in #Acute Myeloid Leukemia (AML)
Found 1 company operating in this sector.
Enliven Therapeutics is a clinical-stage precision oncology company developing allosteric small-molecule therapies targeting validated oncology pathways, with a focus on menin inhibitors for acute myeloid leukemia (AML) and other genetically defined cancers. Its lead program ELVN-001 is being developed for patients with NPM1-mutant and KMT2A-rearranged leukemias.